Daniel Leblanc

Title: The Innovations of Daniel Leblanc

Introduction

Daniel Leblanc is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in pulmonary delivery systems. His work focuses on improving the stability and effectiveness of therapeutic agents administered through the respiratory system.

Latest Patents

Daniel Leblanc holds a patent for "Pulmonary pharmaceutical formulations." This invention provides improved pharmaceutical formulations for pulmonary delivery, which exhibit enhanced chemical and physical stability of the therapeutic, prophylactic, or diagnostic agent compared to existing formulations. The innovative aspect of his formulation includes the use of hydrogenated starch hydrosylate (HSH), which contributes to the improved stability and efficacy of the active agent. The invention also outlines a method for treating various disease conditions by administering these formulations to patients in need.

Career Highlights

Daniel is currently associated with Civitas Therapeutics, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has the potential to significantly impact the treatment of respiratory diseases, providing new avenues for patient care.

Collaborations

Some of his notable coworkers include Charles D. Blizzard and Michael M. Lipp, who contribute to the collaborative environment at Civitas Therapeutics, Inc. Their combined expertise fosters innovation and drives the development of cutting-edge pharmaceutical solutions.

Conclusion

Daniel Leblanc's contributions to pulmonary pharmaceutical formulations exemplify the importance of innovation in healthcare. His patent reflects a commitment to improving patient outcomes through advanced therapeutic delivery systems.